David B Vasily, MD | |
940 N New St, Bethlehem, PA 18018-2756 | |
(610) 866-2010 | |
(610) 866-4359 |
Full Name | David B Vasily |
---|---|
Gender | Male |
Speciality | Dermatology |
Experience | 49 Years |
Location | 940 N New St, Bethlehem, Pennsylvania |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1154327468 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | MD018025E (Pennsylvania) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Lehigh Valley Dermatology Assoc, Ltd. | 7618873514 | 4 |
News Archive
Two new studies led by researchers from the Farncombe Family Digestive Health Research Institute at McMaster University show that transplantation of fecal matter may be a useful tool in the fight against ulcerative colitis (UC).
In a ground-breaking study published in the top journal, Cell, Dr. James Dennis, senior investigator at the Samuel Lunenfeld Research Institute at Mount Sinai Hospital, has discovered a new role for sugars on proteins.
Clinical anxiety affects up to 30 percent of Americans who are in great need of better treatments with fewer side effects.
When reporting medical errors, patients' perceptions of their physicians' disclosure may be key to gaining their trust, according to researchers from the Johns Hopkins Bloomberg School of Public Health. However, a positive perception of the disclosure has little effect on the lawsuit risk a physician faces.
ChemGenex Pharmaceuticals Limited (ASX:CXS) announced today updated clinical data showing that Omapro™ (omacetaxine mepesuccinate) produced durable hematologic and cytogenetic responses in chronic myeloid leukemia (CML) patients who have failed treatment with imatinib and who have developed the Bcr-Abl T315I mutation.
› Verified 8 days ago
Entity Name | Lehigh Valley Dermatology Assoc, Ltd. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1316986763 PECOS PAC ID: 7618873514 Enrollment ID: O20031211000030 |
News Archive
Two new studies led by researchers from the Farncombe Family Digestive Health Research Institute at McMaster University show that transplantation of fecal matter may be a useful tool in the fight against ulcerative colitis (UC).
In a ground-breaking study published in the top journal, Cell, Dr. James Dennis, senior investigator at the Samuel Lunenfeld Research Institute at Mount Sinai Hospital, has discovered a new role for sugars on proteins.
Clinical anxiety affects up to 30 percent of Americans who are in great need of better treatments with fewer side effects.
When reporting medical errors, patients' perceptions of their physicians' disclosure may be key to gaining their trust, according to researchers from the Johns Hopkins Bloomberg School of Public Health. However, a positive perception of the disclosure has little effect on the lawsuit risk a physician faces.
ChemGenex Pharmaceuticals Limited (ASX:CXS) announced today updated clinical data showing that Omapro™ (omacetaxine mepesuccinate) produced durable hematologic and cytogenetic responses in chronic myeloid leukemia (CML) patients who have failed treatment with imatinib and who have developed the Bcr-Abl T315I mutation.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
David B Vasily, MD 940 N New St, Bethlehem, PA 18018-2756 Ph: (610) 866-2010 | David B Vasily, MD 940 N New St, Bethlehem, PA 18018-2756 Ph: (610) 866-2010 |
News Archive
Two new studies led by researchers from the Farncombe Family Digestive Health Research Institute at McMaster University show that transplantation of fecal matter may be a useful tool in the fight against ulcerative colitis (UC).
In a ground-breaking study published in the top journal, Cell, Dr. James Dennis, senior investigator at the Samuel Lunenfeld Research Institute at Mount Sinai Hospital, has discovered a new role for sugars on proteins.
Clinical anxiety affects up to 30 percent of Americans who are in great need of better treatments with fewer side effects.
When reporting medical errors, patients' perceptions of their physicians' disclosure may be key to gaining their trust, according to researchers from the Johns Hopkins Bloomberg School of Public Health. However, a positive perception of the disclosure has little effect on the lawsuit risk a physician faces.
ChemGenex Pharmaceuticals Limited (ASX:CXS) announced today updated clinical data showing that Omapro™ (omacetaxine mepesuccinate) produced durable hematologic and cytogenetic responses in chronic myeloid leukemia (CML) patients who have failed treatment with imatinib and who have developed the Bcr-Abl T315I mutation.
› Verified 8 days ago
Mary E Hutchins, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1665 Valley Center Pkwy, Suite 120, Bethlehem, PA 18017 Phone: 610-868-3150 Fax: 610-868-3156 | |
Dr. Conrad Lee Lentz, Dermatology Medicare: Not Enrolled in Medicare Practice Location: 125 W. Langhorne Ave, Bethlehem, PA 18017 Phone: 610-867-3229 | |
Jenna Marie Kunsman, PA-C Dermatology Medicare: Medicare Enrolled Practice Location: 940 N New St, Bethlehem, PA 18018 Phone: 610-861-9804 Fax: 610-861-9804 | |
Marie E Helmold, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1665 Valley Center Pkwy Ste 120, Bethlehem, PA 18017 Phone: 610-868-3150 Fax: 610-868-3156 |